Kyorin Pharmaceutical Co (TSE:4569) Days Sales Outstanding : 126.53 (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co Days Sales Outstanding?

Kyorin Pharmaceutical Co's average Accounts Receivable for the three months ended in Sep. 2024 was 円37,052 Mil. Kyorin Pharmaceutical Co's Revenue for the three months ended in Sep. 2024 was 円26,720 Mil. Hence, Kyorin Pharmaceutical Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 126.53.

The historical rank and industry rank for Kyorin Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

TSE:4569' s Days Sales Outstanding Range Over the Past 10 Years
Min: 133.69 Med: 147.52 Max: 166.07
Current: 134.49

During the past 13 years, Kyorin Pharmaceutical Co's highest Days Sales Outstanding was 166.07. The lowest was 133.69. And the median was 147.52.

TSE:4569's Days Sales Outstanding is ranked worse than
84.66% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.085 vs TSE:4569: 134.49

Kyorin Pharmaceutical Co's Days Sales Outstanding declined from Sep. 2023 (136.83) to Sep. 2024 (126.53).

Kyorin Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Kyorin Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co Days Sales Outstanding Chart

Kyorin Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Days Sales Outstanding

Get a 7-Day Free Trial

155.88

142.01

143.34

145.05

133.69

Kyorin Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															116.25	129.71	153.20	126.53	-

Competitive Comparison of Kyorin Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Kyorin Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyorin Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyorin Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Kyorin Pharmaceutical Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Kyorin Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Kyorin Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2025 is calculated as

	Days Sales Outstanding (A: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (47714	+	47583)	/	2 )	/	130087	*	365
=	47648.5					/	130087	*	365
=	133.69

Kyorin Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0	+	37052)	/	1 )	/	26720	*	365 / 4
=	37052					/	26720	*	365 / 4
=	126.53

Kyorin Pharmaceutical Co (TSE:4569) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Kyorin Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyorin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

KYRNF:USA

Address

6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311

Website

https://www.kyorin-pharm.co.jp

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co Headlines

No Headlines